Sanara MedTech Reports Q1 2026 Earnings with Revenue Growth and Net Profitability
Sanara MedTech (SMTI) reported strong first-quarter earnings for 2026, achieving a 19% revenue growth compared to the same period in 2025. The company reached GAAP net profitability of $0.4 million or $0.04 per diluted share and noted increased demand for its surgical products.
Tickers: $SMTI